Skip to Content
Agencies | Governor
Search Virginia.Gov

Virginia Board of Pharmacy
Guidance Documents

The Code of Virginia requires annual publication of lists of guidance documents from state agencies. A guidance document is defined as "...any document developed by a state agency or staff that provides information or guidance of general applicability to the staff or public to interpret or implement statutes or the agency's rules or regulations..." Agencies are required to maintain a complete, current list of all guidance documents and make the full text of such documents available to the public.

Copies of the following documents may be viewed during regular work days from 8:15 a.m. until 5:00 p.m. at the offices of the Department of Health Professions, 9960 Mayland Drive, Suite 300, Henrico, Virginia 23233-1463 . Copies may also be downloaded by clicking on the links below or from the Regulatory Townhall at or requested by email at Questions regarding implementation of these documents or requests for copies may be directed to Caroline D. Juran, Executive Director of the Board at the address above or by telephone at (804) 367-4456. Copies are free of charge.

To view the PDF files below you'll need the free Adobe Acrobat Reader 
For the other files you'll need Microsoft Word or the free viewer.

Pharmacists, Pharmacy Intern, and Pharmacy Technician Application Information and Other Guidance

110-2 Information for Applicants for a License as a Pharmacist, revised March 2018

110-17 Instructions for graduates of foreign schools of pharmacy, revised October 2016

110-24 Competency Examination Required for Licensure as a Pharmacist NAPLEX Passing Score, Re-adopted June 21, 2018

110-33 Pharmacy Interns as Pharmacy Technicians, Pharmacy Technician Ratio, Re-adopted December 18, 2018 (pdf file)

110-4 Guide to Continuing Pharmacy Education Requirements, revised December 11, 2017

110-20 Practice by a Pharmacy Technician Trainee, revised March 21, 2017


Pharmacy Permit and other Facility Application Guidance (PIC responsibilities, non-resident information)

110-1 List of categories of facility licenses and a brief description of each, effective November 28, 2019

110-27 Pharmacist-In-Charge responsibilities, effective February 6, 2020

110-28 Guidance for free clinic pharmacy permit applicants, Re-adopted December 18, 2018 (pdf file)

110-34 Manufacturer and Wholesale Distributor Licensure Guidance, effective February 6, 2020

110-38 Requirement for Non-resident Pharmacies to Submit Current Inspection Report, revised December 12, 2016

110-30 Allowances to Purchase, Possess, and Administer Drugs within a Public or Private Animal Shelter revised August 8, 2019 (pdf file)

110-31 Approved capture drugs and drug administering equipment, Directive from the State Veterinarian, revised September 29, 2016


Guidance Concerning Disciplinary Processes and Standard Sanctions for Violations and Inspection Deficiencies

110-9 Pharmacy Inspection Deficiency Monetary Penalty Guide, Revised June 21, 2018

110-42 CE Audit and Recommended Sanctions, Re-adopted December 18, 2018 (pdf file)

110-15 Delegation of Authority for Disciplinary Matters, effective February 6, 2020

110-21 Sanctioning Reference Points Instruction Manual, revised December 2018 (pdf file)

110-23 Practitioner of the Healing Arts Selling Controlled Substances Inspection Deficiency Monetary Penalty Guide, effective February 6, 2020

110-37 Guidance for conducting informal fact-finding by an agency subordinate, Re-adopted December 18, 2018 (pdf)


Pharmacy Practice and Dispensing Physician Guidance

110-6 Guidance for Pharmacies within Opioid Treatment Programs, effective November 28, 2019

110-7 Practitioner/patient relationship and the prescribing of drugs for family or self, effective November 28, 2019

110-8 Information on prescriptive authority in Virginia, revised January 15, 2016

110-41 Changes a Pharmacist May Make to a Prescription Written for a Schedule II Controlled Substance, Re-adopted December 18, 2018 (pdf file)

110-5 Instructions and forms for reporting of thefts or losses of drugs, revised March 29, 2018

Click here to obtain the DEA Form 106 for reporting theft or unusual loss of controlled substances

110-35 Guidance On Virginia Prescription Requirements, Revised September 26, 2017

110-25 Guidance for life of a prescription when the prescriber is no longer in practice, re-adopted June 21, 2018

110-3 Guidance on alternate delivery of prescriptions, pharmacy to physician or pharmacy to controlled substance registration type of delivery, Re-adopted December 18, 2018 (pdf file)

110-32 Use of drop-boxes for collection of prescriptions, Re-adopted December 18, 2018 (pdf file)

110-36 Compliance with USP Standards for Compounding, effective November 28, 2019

110-29 Guidance Document for physician dispensing, revised June 14, 2016

110-11 Proof of Identity when Dispensing Schedule II Drugs, re-adopted June 21, 2018

110-16 Performing Inventories, revised June 21, 2018

110-22 Use of Dispensing Records to Identify Pharmacist Responsible for Dispensing Error, re-adopted June 21, 2018

110-43 Dispensing with an Authorized Generic, adopted December 18, 2018 (pdf file)

110-39 Guidance for Continuous Hours Worked by Pharmacists and Breaks, adopted March 21, 2017

110-40 Storage of Schedule II Drugs in a Pharmacy, Re-adopted December 18, 2018 (pdf file)

110-44 Protocol for the Prescribing and Dispensing of Naloxone, November 28, 2019

110-46 Delivery of Dispensed Drugs, adopted December 11, 2017

110-47 Guidelines for Provision of Counseling and Information by Pharmacists regarding Proper Disposal of Unused Dispensed Drugs, revised March 29, 2018


Miscellaneous Guidance

110-18 Interpretation of "administer" to include preparation for administration, revised September 29, 2015

110-10 Providing pharmacy services from mobile vans to indigent or underserved populations, re-adopted June 21, 2018

110-12 Bylaws of The Virginia Board of Pharmacy, revised September 26, 2017

110-19 Transferring Valid Orders between Medical Equipment Suppliers, re-adopted June 21, 2018

110-13 Guidance on collaborative practice agreements, effective February 6, 2020

110-14 Guidance on a statistically valid sample size for pharmaceutical processors, effective February 6, 2020